Sfoglia per AUTORE
SPADI R
Collezione AOU Città della Salute di Torino

  

Items : 24

Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance. in Cancer investigation / Cancer Invest. 2025 Jan;43(1):59-69. doi: 10.1080/07357907.2024.2432013. Epub 2024 Nov 27.
2025
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino

Di Maio M; Brunetti O; Spadi R; Ilaria D; Rimini M; Tavolari S; Palloni A; Deserti M; Scartozzi M; Faloppi L; Santini D; Lutrino SE; Aprile G; Sperti E; Salani F; Silvestris N; Satolli MA; Casadei-Gardini A; Leone F; Filippi R; Brandi G;

A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] / Pancreatology. 2024 Nov;24(7):1066-1072. doi: 10.1016/j.pan.2024.09.006. Epub 2024 Sep 12.
2024
AOU Città della Salute di Torino

Carconi C; Bosi C; Scartozzi M; Cergnul M; Cinausero M; Faloppi L; Garajova I; Lonardi S; Pecora I; Pisanu L; Spadi R; Spallanzani A; Peretti U; Macchini M; Orsi G; Reni M;

A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia. in EMBO reports / EMBO Rep. 2024 Apr;25(4):1886-1908. doi: 10.1038/s44319-024-00104-x. Epub 2024 Feb 27.
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino

Arese M; Lawlor R; Di Maio M; Cappello P; Scarpa A; Parab S; Novelli F; Allavena P; Papotti M; Cristiano C; Spadi R; Vallariello E; Hoza RM; Metovic J; Astanina E; Middonti E; Bussolino F;

2024
AOU Città della Salute di Torino

Cappello P; Giordano D; Campra D; Satolli MA; Spadi R; Genuardi E; Bonello L; Arigoni M; Calogero R; Curcio C; Bulfamante S; Brugiapaglia S; Cordero F; Novelli F;

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma. in Cancer medicine / Cancer Med. 2023 Jul;12(13):14337-14345. doi: 10.1002/cam4.6111. Epub 2023 Jun 6.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Casalino S; Spadi R; Zaniboni A; Scartozzi M; Antonuzzo L; Milella M; De Vita F; Barsotti G; Zecchetto C; Pinto C; Zichi C; Giordano G; Satolli MA; Noventa S; Pretta A; Giommoni E; Vaccaro V; Fasano M; Merz V; Procaccio L; Bergamo F; De Toni C; Melisi D; Lonardi S;

Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival. in Clinical and experimental medicine / Clin Exp Med. 2023 Dec;23(8):5089-5100. doi: 10.1007/s10238-023-01236-5. Epub 2023 Nov 1.
2023
AOU Città della Salute di Torino

Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F;

Oncological patient management on the territory: the results of a survey in the north-west of Italy. in Pharmacy practice / Pharm Pract (Granada). 2022 Oct-Dec;20(4):2716. doi: 10.18549/PharmPract.2022.4.2716. Epub 2022 Oct
2022
ASL Città di Torino
AOU Città della Salute di Torino

Ala A; Pignata I; Brusa P; Spadi R; Icardi M; Comandone A; Quaglino P; Enri LR; Vicenzi G; Baratta F;

Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Apr;34(2):123-132. doi: 10.1080/1120009X.2021.1953887. Epub 2021 Jul 27.
2022
ASL Biella
AOU Città della Salute di Torino

Brandi G; Brunetti O; Aglietta M; Giulia O; Fenocchio E; Spadi R; Garattini SK; Vivaldi C; Lombardi P; Frega G; Russano M; Lutrino SE; Scartozzi M; Satolli MA; Palloni A; Casadei-Gardini A; Silvestris N; Aprile G; Fornaro L; Leone F; Filippi R;

The importance of a multidisciplinary care: community pharmacies as a hub to support oncologic patients with cutaneous reactions due to treatments. in Italian journal of dermatology and venereology / Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):79-80. doi: 10.23736/S2784-8671.19.06418-6.
2021
AOU Città della Salute di Torino

Pignata I; Vicenzi G; Ravetto Enri L; Baratta F; Quaglino P; Comandone A; Ala A; Icardi M; Spadi R; Brusa P; Pignata I; Vicenzi G; Ravetto Enri L; Baratta F; Quaglino P; Comandone A; Ala A; Icardi M; Spadi R; Brusa P;

In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001071. doi: 10.1136/jitc-2020-001071.
2020
AOU Città della Salute di Torino

Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F;

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Hanash SM; Evangelista A; Satolli MA; Spadi R; Giordano D; Momin AA; Capello M; Hong W; Katayama H; Ferrero G; Follia L; Mandili G; Cordero F; Novelli F;

Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit. in World journal of surgical oncology / World J Surg Oncol. 2020 Apr 2;18(1):65. doi: 10.1186/s12957-020-01844-5.
2020
AOU Città della Salute di Torino

Bertero L; Spadi R; Osella-Abate S; Mariani S; Castellano I; Gambella A; Racca P; Morino M; Cassoni P;

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. in Clinical colorectal cancer / Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.
2019
ASL Biella
ASL VCO
AO Ordine Mauriziano
AOU Città della Salute di Torino

Lièvre A; Montagnani F; Vasile E; Brac C; Aglietta M; Clerico M; Passardi A; Buscaglia P; Meurisse A; Pasquini G; Neuzillet C; Falcone A; Spadi R; Edeline J; Sperti E; Musettini G; Satolli MA; Vernerey D; De Luca E; Vivaldi C; Lombardi P; Vienot A; Casadei-Gardini A; Leone F; Fornaro L;

Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. in Frontiers in oncology / Front Oncol. 2019 Feb 27;9:115. doi: 10.3389/fonc.2019.00115. eCollection 2019.
2019
AOU Città della Salute di Torino

Follia L; Ferrero G; Mandili G; Beccuti M; Giordano D; Spadi R; Satolli MA; Evangelista A; Katayama H; Hong W; Momin AA; Capello M; Hanash SM; Novelli F; Cordero F;

Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients. in Medical oncology (Northwood, London, England) / Med Oncol. 2018 Oct 4;35(12):150. doi: 10.1007/s12032-018-1211-7.
2018
AOU Città della Salute di Torino

Martini S; Arcadipane F; Strignano P; Spadi R; Contu V; Fiandra C; Ragona R; Catalano G; Satolli MA; Camandona M; Romagnoli R; Ricardi U; Franco P; Martini S; Arcadipane F; Strignano P; Spadi R; Contu V; Fiandra C; Ragona R; Catalano G; Satolli MA; Camandona M; Romagnoli R; Ricardi U; Franco P;

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. in PloS one / PLoS One. 2018 Jan 19;13(1):e0191593. doi: 10.1371/journal.pone.0191593. eCollection 2018.
2018
AOU Città della Salute di Torino

Spadi R; Avallone A; Reni M; Aprile G; Satolli MA; Nasti G; Cereda S; Gammaitoni L; Cagnazzo C; Fenocchio E; Cavalloni G; Peraldo-Neia C; Venesio T; Martin V; Doglioni C; Frattini M; Aglietta M; Leone F;

Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials. in Medical oncology (Northwood, London, England) / Med Oncol. 2017 Mar;34(3):40. doi: 10.1007/s12032-017-0898-1. Epub 2017 Feb 7.
2017
AOU Città della Salute di Torino

Franco P; Arcadipane F; Strignano P; Spadi R; Trino E; Martini S; Iorio GC; Satolli MA; Airoldi M; Romagnoli R; Camandona M; Ricardi U;

Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district. in Tumori / Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000405.
2016
AOU Città della Salute di Torino

Ponzetti A; Pinta F; Spadi R; Mecca C; Fanchini L; Zanini M; Ciuffreda L; Racca P;

2016
AOU Città della Salute di Torino

Siena S; Ciuffreda L; Fasola G; Aprile G; Cagnazzo C; Amatu A; Montano M; Nasti G; Spadi R; Belli C; Filippi R; Cereda S; Marino D; Leone F; Reni M; Aglietta M;

Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. in World journal of clinical oncology / World J Clin Oncol. 2016 Feb 10;7(1):27-43. doi: 10.5306/wjco.v7.i1.27.
2016
AOU Città della Salute di Torino

Spadi R; Brusa F; Ponzetti A; Chiappino I; Birocco N; Ciuffreda L; Satolli MA;

Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer. in Clinical oncology (Royal College of Radiologists (Great Britain)) / Clin Oncol (R Coll Radiol). 2016 Aug;28(8):505-12. doi: 10.1016/j.clon.2016.02.001. Epub 2016 Feb 18
2016
AOU Città della Salute di Torino

Filippi AR; Guerrera F; Badellino S; Ceccarelli M; Castiglione A; Guarneri A; Spadi R; Racca P; Ciccone G; Ricardi U; Ruffini E; Filippi AR; Guerrera F; Badellino S; Ceccarelli M; Castiglione A; Guarneri A; Spadi R; Racca P; Ciccone G; Ricardi U; Ruffini E;

Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. in International journal of radiation oncology, biology, physics / Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):524-9. doi: 10.1016/j.ijrobp.2014.10.046. Epub 2014 D
2015
AOU Città della Salute di Torino

Ragona R; Spadi R; Monagheddu C; Franco P; Guarneri A; Ceccarelli M; Badellino S; Filippi AR; Racca P; Ricardi U;

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jun;26(6):1188-1194. doi: 10.1093/annonc/mdv112. Epub 2015 Feb 23.
2015
AO Cuneo
AOU Città della Salute di Torino

Di Donato S; Granetto C; Bonetti A; D'Amico M; Vitello S; Longarini R; Barone C; Tonini G; Spadi R; Zaniboni A; Tomasello G; Cortesi E; Salvatore L; Masi G; Lonardi S; Antoniotti C; Cremolini C; Loupakis F; Boni L; Falcone A;

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. in The New England journal of medicine / N Engl J Med. 2014 Oct 23;371(17):1609-18. doi: 10.1056/NEJMoa1403108.
2014
AOU Città della Salute di Torino

Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A;